Abstract
FORMULATION DEVELOPMENT & IN VITRO EVALUATION OF IMMEDIATE RELEASE TABLETS OF NEVIRAPINE CYCLODEXTRIN COMPLEXES

M. V. Priyanka* and D. Dhachinamoorthi

ABSTRACT

Nevirapine is an Anti-retro viral agent using in the management of HIV diseases. It is very slightly soluble in water. In the present study attempt has been made to prepare and characterize inclusion complex of Nevirapine with β-Cyclodextrin. The phase solubility analysis indicated he formation of 1:1 molar inclusion complex of Nevirapine with β -CD. Apparent stability constant (Kc) was found o be 164.557 M-1. The inclusion complexes prepared by different methods viz. Physical mixture and Solvent evaporation methods. The prepared complexes were characterized using FT-IR. Further, the inclusion complexes containing Nevirapine: β-Cyclodextrin (1:2) was formulated into immediate release tablets which are stable and enhancing in solubility and faster dissolution. For the development of Nevirapine tablets, the excipients selected were Starlac as diluents, Croscarmellose sodium and Sodium Starch Glycolate as super disintegrants, Microcrystalline cellulose (MCC) as binding agents, Aerosil as glidant, Magnesium Stearate as lubricant. The formulation blend was evaluated for Precompression studies and compressed tablets were evaluated for post compression studies and the results were found to be within the limits. The compatibility studies were performed which resulted in no interactions between drug and excipients.

Keywords: Nevirapine, ?-Cyclodextrin, Starlac, Croscarmellose sodium, Sodium starch glycolate.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • EJBPS: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2026 Issue has been successfully launched on 1 FEBRUARY 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT